Toxoplasma gondii ROP18I inhibits host innate immunity through cGAS-STING signaling
Min Chen, Lijie Yao, Lijuan Zhou, Pei Yang, Weihao Zou, Liqing Xu, Shengmin Li, Hongjuan Peng
Journal:FASEB JOURNAL
IF:5.83
DOI:10.1096/fj.202101347R
PMID:35084749
Published:2022-01-27
research field:神经科学分子生物学老年医学神经免疫学麻醉学
Abstract
Toxoplasma gondii is an opportunistic protozoan, which widely infects humans and other warm-blooded animals. The type I interferon (IFN) such as IFN-α/β is involved in cGAS-STING signaling to resist T . gondii infection. We found in RAW264.7 cells, that T . gondii virulence factor Tg ROP18 I , inhibited IFN-β production through interacting with interferon regulatory factor 3 (IRF3). Besides, Tg ROP18 I interacted with p62 and Tumor Necrotic Factor Receptor Associated Factor 6 (TRAF6), which resulted in the inhibition of TRAF6-p62 interaction, and phosphorylation of p62. Furthermore, Tg ROP18 I restricted the recruitment of ubiquitin, p62 and microtubule-associated protein light chain 3 (LC3) to the parasitophorous vacuole membrane (PVM) in IFN-γ-stimulated murine cell line L929 cells. In IFN-γ-stimulated human cells, Tg ROP18 I restricted the decoration of PVM with ubiquitin, p62, and LC3, and bound with TRAF2, TRAF6, and p62, respectively. As a result, Tg ROP18 I led to a successful parasitic replication in murine and human cells. Collectively, our study revealed the function of Tg ROP18 I in suppressing host type I interferon responses in T . gondii infection for parasitic immune escape.
本文使用的Yeasen产品


